Stay updated with breaking news from Erics Lander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Rating) have earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among […]
Mizuho initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research report sent to investors on Wednesday morning, The Fly reports. The firm issued a neutral rating and a $2.00 price objective on the biopharmaceutical company’s stock. Several other research firms have also recently commented on VSTM. Royal Bank of Canada reaffirmed […]
Mizuho initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research report issued on Wednesday, The Fly reports. The brokerage set a “neutral” rating on the biopharmaceutical company’s stock. Several other equities analysts also recently issued reports on the stock. HC Wainwright reaffirmed a “buy” rating and set a $3.00 price target […]
Verastem, Inc. (NASDAQ:VSTM – Get Rating) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,620,000 shares, an increase of 39.7% from the February 28th total of 1,160,000 shares. Based on an average trading volume of 788,100 shares, the days-to-cover ratio is currently […]
StockNews.com began coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts also recently issued reports on VSTM. HC Wainwright reissued a buy rating and issued a $3.00 target price on shares of […]